Study heart function and frailty in people with aortic valve narrowing
Part of Heart & circulation clinical trials.
This study looks at how heart mechanics, blood markers, and frailty relate to symptoms and heart measurements in people with aortic stenosis (a stiff, narrowed heart valve). It may help doctors better understand who is at higher risk and how disease changes over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- If you’re in the patient group: have aortic stenosis by an ultrasound (Doppler echo) with one of these categories: moderate, severe, or “heart failure with preserved pumping strength” (LVEF 45% or higher)
- If you’re in the healthy control group: be generally healthy and able to follow screening requirements
- Have not had valve replacement surgery or a transcatheter valve procedure before
- Not have certain recent major events (like heart attack in the last 3 months or stroke/TIA in the last 6 months)
- Be able to do a 6-minute walk test (6MWTD) and not have conditions that would prevent it
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood and/or body signals (called biomarkers) to understand why aortic valve narrowing may worsen and what outcomes people have. You may be able to help researchers by undergoing regular heart care plus additional testing like MRI or CT if you qualify.
This study looks for biological markers in the blood that might help predict heart-related events in people with a narrowed aortic heart valve. It aims to improve care for those with this condition, whether or not they have a procedure called TAVI to replace the valve.
This study tests whether remote monitoring (checking in from home) can help people with a common heart valve condition called aortic stenosis. It aims to see if this approach can keep you out of the hospital and improve your quality of life.
This study looks at whether people with both severe aortic valve narrowing and cardiac amyloidosis (a buildup of abnormal proteins in the heart) can benefit from a valve replacement procedure. It may help doctors understand how common this combination is and how to improve care.
This trial studies whether lowering blood pressure affects health outcomes in people who have valve narrowing in the heart but no valve symptoms yet. It may help you understand which blood pressure targets are safest when the aortic valve is not fully opening.
This study follows adults who are having aortic valve replacement (through surgery or a catheter) to see how often certain outcomes happen after the procedure. You may be asked for blood tests and scans at set times, and some people may also be offered a special CT scan.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.